Thank you Keti. This is a good summary of the issues.  For decision support, we might want to consider drug interactions and not just drug instructions.

Regards,

Ahmad

Dear colleagues, sending you the slightly updated list, which includes our recommendations as well.

There are some fundamental questions, like which model to follow or how to incorporate the generic drug policy and to what extent? As well as questions that probably can be referred to Ministry’s legal dep., like: role of the pharmacist and the roles and responsibilities in general. However this is one of the key questions to be decided on a policy level, at the same time.

So, on a more general level… as soon as the key issues are clarified, we can move on to the mockup design stage…and we start from the solid ground in the face of tech. requirements docs prepared by Ahmad.

Aleko what is the expectation from the Ministry side? We have shared all the technical docs already, so do you think sharing only the mockups and discussing them during the design stage is enough or some education is needed to be done before?

Ketevan Tatoshvili

Provider Capacity and Quality Improvement Programs Officer

Abt Associates Incorporated - Georgia

USAID Health System Strengthening Project

1B, Budapest Street, 5th floor

Tbilisi 0160, Georgia

Tel. (995 32) 2388 733, 2388 734; ext. 102

Fax: (995 32) 2388 735

This message may contain privileged and confidential information intended solely for the addressee. Please do not read, disseminate or copy it unless you are the intended recipient. If this message has been received in error, we kindly ask that you notify the sender immediately by return email and delete all copies of the message from your system. Thank you.